Breast Cancer and Quality of Life

The study aims to analyse and decode interviews of patient with breast cancer, and then established according a multidimensional profile specific to the population and to create a questionnaire tha will allow a practical and qualitative evaluation of the quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Observational

Primary location

François Baclesse Center, Caen, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age < 45
non metastatic breast cancer
at least 6 months of relationship

Exclusion criteria

no life partner
inclusion criteria failure

Treatment and study plan

Interview

Behavioral

psychological, emotional, family and social parameters

Primary outcomes

quality of life at different time of medical follow up

Time frame: 6 months after diagnosis, 1 year after diagnosis, between 2 and 7 years after diagnosis, 7 years past diagnosis

interviews with couples at different time frame depending on which group they are in

Sponsors and collaborators

Lead sponsor

Centre Oscar Lambret

Other

Registry information

Official study title

Impact of Breast Cancer on Quality of Life of the Young Women, Her Life Partner and Her Couple

Acronym: KALICOU

Important dates

Study start: 2007
Primary completion: 2008
Study completion: 2008
First posted: Aug 10, 2012
Registry last updated: Mar 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed